Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Who co-authored the white paper? Intel.
The importance of the white paper is the AI, it's use and who co-authored it.
ENZC is a drug development company with multiple projects in its pipeline, most being worked on by Samsung.
The opportunity in Africa and the IPF Immune appear to be the first real revenue - but revenue from the sale of the distributorships counts too.
It looks like he's doing was Investor Relations reps are supposed to do.
The reality is that the whole concept of outside auditors
is one used across all industry, not just small companies, but ALL companies
Outside auditors have standards and they sell those standards certifying certain information to outside investors.
Arguably, this creates a level of credibility for ENZC, as the outside auditors wouldn't certify without compromising their integrity.
It's something to be welcomed, not denigrated.
DEBUNKED!!! When was ENZC accused
by a regulatory agency of a pump and dump?
The whole issue of “pump and dump” is comical. If that were an issue, the company would have been reported FINRA/SEC/OTC markets and those entities would have published it.
If someone has evidence of a problem - report it. If not, why speculate negatively with no evidence?
Tangible, clear progress:
- There are 2 hospitals in the heart of the HIV epidemic who want to move forward.
- They are looking to treat up to 30,000 patients!
- IPF Immune has been announced to hit the market.
Overall, there is clear progress based on PR's from the company.
Not sure where anyone gets ENZC traded auditors.
ENZC hired a more specific specialist accounting firm to help with the 251(g) accounting requirements. PCAOB auditors don't let you put out press releases about their progress. The whole idea of independent auditors is that they do NOT squawk about what they are doing. That independence is the point.
Hiring expert consultants ENZC is frankly gratifying and exactly what professional managers should be doing - and doing that is indeed in the shareholders' best interest.
Malone Bailey is still the auditor, I checked last week.
It seems like NEGATIVE outsiders
know more than anybody. Hmmmmmm......
No officer is hiding, ENZC has fully disclosed all issues related to shares and with respect to officer holdings. No strange sales, no dilution since Oct 2020 (when the price was $0.0001).
Baseless speculation has no place here.
There is no dilution since Oct 2020 and there has been no mention of any kind of a reverse.
I do not think they have a need to reverse.
Pure end of the week speculation with no basis.
The people that believe In the company are buying up what anyone is selling and the flippers run out of stock to flip because investors are holding it
Some technical analysis of a particular set of transactions regarding Livingston.
Let’s look at the ENZC trading volume back in March of 2020:
https://finance.yahoo.com/quote/ENZC/history?period1=1582934400&period2=1584921600&interval=1d&filter=history&frequency=1d&includeAdjustedClose=true
Daily volume is shown in black. Certain dates, shown in blue, have virtually zero volume - Look at the two dates, one with zero (!) volume and the other with 300 shares at $0.0002 - a 6 cent trade - lololol.
THEN on March 12, 2020, Livingston is issued 114 million shares. The day earlier, March 11, 2020, the volume shoots up from virtually nothing to 155 million shares @ $0.0002 - $31,000 total, shown in red.
It's painfully clear that all the issuance of 114 million shares of stock to Livingston on March 12 was known and sold the previous day (March 11) for about $31,000. It is obvious that on this particular transaction, the shares issued were sold into the market, and remain in the public float to this day.
This pattern exists at every issuance of 3(a)10 shares to Livingston.
All upside in the shares was clearly realized by those retail investors who purchased the Livingston shares and sold later during one of the multiple turns of the float.
They hired NPI to go, so NPI should be attending - representing ENZC.
To be clear, each shareholder decides on his/her own when to turn shares into unrestricted. This is normal and natural, and is compliant with SEC 114 rules.
Also part of the SEC rules is to disclose when Authorized Shares are increased or if additional Shares are issued. You would see that in an increase in Outstanding Shares.
Since Oct 2020, there have been no increase in shares and no increase = zero dilution.
If something was nefarious, the company would the been reported and the regulatory agencies FINRA/SEC/OTC markets would have published something.
When was ENZC accused
by a regulatory agency of a pump and dump?
The whole issue of “pump and dump” is tiresome. If that were an issue, the company would have been reported FINRA/SEC/OTC markets and those entities would have published it.
Those regulatory agencies would have also interceded in the trading if there was a shred of evidence of truth to these allegations.
There was much discussion in the 2020 timeframe about such things - when the price of the stock was $0.0001. Since then the following has happened:
1) ENZC combines with Bioclonetics
2) ENZC restructures debt.
3) Many distribution agreements signed
4) IPF Immune announced and distribution secured
5) Many key executives added
End of Day...look at VWAP. Beware...
Right now ENZC VWAP is currently $0.0788.
People might sell a small amount at the end of the day at .0787 to try to show a close in the red
"Painting the tape"
Reports contain proprietary information protected by non-disclosures to protect the patent. No one can get access BECAUSE it is proprietary. Unless.....the person talking about this is a party to the agreement?
Hmmmmm....shifting away from the dilution and pump and dump lies to good old fall back position of Harry Zhabilov, who gave up control in October/20 to CC.....
AND facilitated the Bioclonetics transaction with his own shares.
This made the cost of the transaction zero in new shares, which would have been dilutive - a particularly impressive gesture.
Doesn’t the company under SEC/OTC/FINRA guidelines have to address false and misleading statements in the public domain?
These type of statements being repeated day after day that are contrary to publicly available information clearly did draw a response from ENZC in order to provide information filed in OTC reports.
It strikes me that it’s management’s duty to protect shareholder value. I am glad to see a proactive company approach.
The shares falsely referred to as currently “diluting” were issued in 2019/2020 - as shown in the supplemental info. There was no dilution in 2020/2021 because of the disclosures that show increase in Outstanding Shares.
All the impact from any additional shares issued in 2019 and 2020 was realized at that time. That’s when the Livingston shares were clearly sold in the market, and they have clearly turned numerous times. The Livingston shares transferred at prices below $0.0145 and are in the public hands.
(And by the way, the price is up substantially AFTER those shares were clearly sold became unrestricted - up to $0.08.)
Livingston had a zero position in Enzc shares at 11-01-2020. Trace the conversions and the increase in trades on the historical data on trades.
The increase in float was normal and natural and followed SEC 114 guileless - from individuals that invested prior to 10/15/2020 and elected to remove the restrictions.
Dilution is based on Outstanding Shares, not Float.
Outstanding Shares has not increased one iota since Oct 2020
Float has drifted up in a normal and natural way, as per SEC 144 rules.
And, the price of the shares has gone from $0.0001 to almost $0.08 during this period.
“Company filings don't lie”. YES, YES, YES!!! That’s true!!!!
And the filings is are what analysis should be based upon.
The data and the filings are solid, it’s the interpretation of that data that can be manipulated to mislead.
Read the supplemental info provided by the company that gives a detailed analysis . The float increased in 2019 and 2020. All the increase in float traded many times over since 9/30/2020.
Looking at Yahoo historical trading data, there have been about 7.6 BILLION shares traded since the end of 2020 (that is adding up the daily volume of shares traded). Any shares that settled long ago have clearly been sold and resold many times - they have been fully absorbed LOOOOOOOONG AGO. Certainly mostly prior to the stock price run up - from $0.0001 to $0.077 or so today.
“Float” has turned over many times - all the shares are in public hands.
Simple math shows that it’s impossible for their trading to be anything remotely like a pump and dump.
For those unfamiliar with SEC 144 rules...
The float has gone up since 12/31/2019 in a normal and natural evolution. By the SEC 144 requirements, shares that were issued to investors have aged.
Increase in float has nothing to do with a management decision. It's individual shareholders exercising their right to manage their property as they wish. No pump and dump, no insider trading or anything nefarious. It is all right there in the filings.
https://discover.shareworks.com/financial-reporting/what-is-equity-dilution
Equity dilution in startups is defined as the decrease in equity ownership for existing shareholders that occurs when a company issues new shares. In other words, dilution decreases a shareholder’s ownership stake in a startup. However, there are additional factors outside of issuing new stock that can also decrease a shareholder’s equity.
A subject near and dear to entrepreneurs, equity dilution is an important topic to understand for both leaders at private companies and particularly, startups. Typically, a founder starts out owning 100% of the company and, every time capital is raised, or shares are issues, the overall proportion of equity owned by the founder is reduced. Below, we go over the definition of stock dilution and provide you with a hypothetical dilution of shares example and what it can look like in action.
The Meaning of Diluted Shares
Equity Dilution takes place when a company issues new stock. Most often, this results in decrease in the ownership percentage of a shareholder. A phenomenon that goes by many names, equity dilution is also known as “founder dilution,” “stock dilution,” “private company dilution,” and “startup dilution.”
If you’ve ever made orange juice from concentrate, you can already picture how equity dilution works. When you put the concentrate in a pitcher and add water to it, the original concentrate represents only a small portion of the remaining combination. The same is true for cap tables.
Spotlight:
Stock dilution, also known as share dilution is the decrease in existing shareholders’ ownership of a company as a result of the company issuing new equity. We call this “narrow” dilution. It can also refer more broadly to the result of any action that decreases the economic value of existing shareholders’ ownership. We call this “broad” dilution.
Wasn't it $0.0001 to $0.08?
What am I missing?
Correct! - facts matter.
We should look for these types of data points. But in fairness, when ENZC puts out these PR's, it is a GOOD thing. Shows progress. Not the hard data that Jack (and most of us) would like, but it's good.
When progress is not updated...THEN the assumption of failure or (truly!) weird conspiracy theories take over, most of which have little/no basis in fact.
1) "Dilution"
Zero dilution since Oct 2020. ----> Zero new shares issued = zero dilution
("Float" is virtually meaningless when discussing dilution)
2) Price: In the past 18 months, the price has gone UP from $0.0001 to $0.08 - 800 times.
Since Oct 2020, when the sat
$10,000 invested in early 2020 would now be worth $8 million.
(Sigh) more weirdness.
Let’s talk facts:
1) “Dilution “ is not present when Outstanding Shares is unchanged.
2) The shares that matured due to debt conversion have been absorbed by the market LOOOOOONG ago.
3) Public disclosures show stability in shares outstanding , shares authorized, no changes in auditors, accounting firms, etc.
4) Public disclosures show significant progress in at least two areas: ITV-1 and the spray.
Company looks to be hitting expectations on what’s been disclosed publicly. Now, can ENZC hit weird expectations from board? Probably not. But, that’s not the standard. But, looking at filings, ENZC looks to be on track.
Smart analysts looks at public disclosures, and use REAL accounting definitions and real, tried-and-true financial analysis.
Onward!
PLUS, there would have to be disclosure
if there were any change in auditor. There has been no such disclosure.
It's frankly infuriating that people make up weird scenarios that are refuted by disclosures (or the absence thereof). FINRA / SEC have requirements on disclosure - and the existence of shenanigans is the exact reason for those requirements.
ENZC is in compliance - which makes me happy.
Onward!
Weird definitions....AGAIN.
To clarify: A pump and dump is an artificial run up of the shares of common stock of a company where you put out false press and you sell your own shares. The shares you are talking about are preferred shares and are not registered and cannot be sold in the market. There has been no new issuance of common shares nor any conversion according to the OTC filings.
Weirdness again,
To be clear:
1) Authorized shares is unchanged, and would have to be made public.
2) Float does not equal dilution, no matter how many weird math definitions are used
Weird analysis
To be clear - Dilution is directly defined as an increase in outstanding shares, not traceable.
30,000 potential patients??
For ITV-1.
That's terrific. And, the press release announcing the Enzolytics IPF Immune(™)?
Serious momentum.
Onward!!
Tweets are not Press Releases
There has been no PR's from ENZC regarding dates of milestones. The misleading information is coming from SPECULATION in these posts, not from PR's from the company.
Overall, there is clear progress. The PR's have specificity in the following:
- There are 2 hospitals in the heart of the HIV epidemic who want to move forward.
- They are looking to treat up to 30,000 patients!
Holy crap, that's substantial.
Onward, baby!
Press Release- ITV-1 in Africa!
https://finance.yahoo.com/news/enzolytics-inc-wholly-owned-subsidiary-113000423.html
ONWARD!
REAL product(s) being launched - terrific news
Yesterday's press release
https://finance.yahoo.com/news/enzolytics-ipf-immune-tm-immune-120000119.html
show some real, tangible progress. No weird conspiracy theories, no strange ALL CAPS!!! assertions.
Just solid progress.
Onward!
I’m optimistic. Revenue coming and no dilution
PR (and Chandra Twitter) announce spray sales coming soon. No dilution since October 2020
Things are looking good.
Onward!
More weird definitions
There is no dilution, since no new shares since Oct 2020
Restricted shares maturing is normal and natural
(or for fanboIs "NORMAL AND NATURAL")
Has anyone else seen the post on the Regeneron message board about Dr. Suraj Kumar Saggar that ENZC just added to advisory board?